HealthStream (NASDAQ:HSTM – Get Free Report) had its target price upped by stock analysts at Canaccord Genuity Group from $29.00 to $30.00 in a research report issued on Wednesday,Benzinga reports. The brokerage presently has a “hold” rating on the technology company’s stock. Canaccord Genuity Group’s price target would indicate a potential downside of 7.21% from the company’s previous close.
Other equities research analysts have also issued reports about the company. William Blair reaffirmed an “outperform” rating on shares of HealthStream in a research report on Tuesday. JMP Securities reissued a “market perform” rating on shares of HealthStream in a research report on Thursday, February 6th. Two investment analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, HealthStream currently has an average rating of “Moderate Buy” and an average price target of $32.00.
Read Our Latest Stock Analysis on HealthStream
HealthStream Price Performance
HealthStream (NASDAQ:HSTM – Get Free Report) last posted its quarterly earnings data on Monday, February 24th. The technology company reported $0.16 EPS for the quarter, beating analysts’ consensus estimates of $0.13 by $0.03. The company had revenue of $74.24 million for the quarter, compared to analyst estimates of $73.55 million. HealthStream had a net margin of 6.84% and a return on equity of 5.67%. During the same period in the previous year, the business posted $0.14 earnings per share. As a group, sell-side analysts anticipate that HealthStream will post 0.63 EPS for the current fiscal year.
Institutional Trading of HealthStream
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Barclays PLC lifted its position in HealthStream by 145.0% during the third quarter. Barclays PLC now owns 58,838 shares of the technology company’s stock valued at $1,697,000 after purchasing an additional 34,821 shares during the last quarter. Robeco Institutional Asset Management B.V. boosted its holdings in shares of HealthStream by 26.9% in the fourth quarter. Robeco Institutional Asset Management B.V. now owns 76,260 shares of the technology company’s stock worth $2,425,000 after buying an additional 16,166 shares during the last quarter. State Street Corp lifted its position in shares of HealthStream by 1.2% during the 3rd quarter. State Street Corp now owns 974,235 shares of the technology company’s stock valued at $28,097,000 after buying an additional 11,976 shares in the last quarter. JPMorgan Chase & Co. boosted its holdings in HealthStream by 18.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 57,204 shares of the technology company’s stock worth $1,650,000 after buying an additional 9,017 shares during the period. Finally, Harbor Capital Advisors Inc. grew its holdings in HealthStream by 141.2% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 400,033 shares of the technology company’s stock valued at $11,537,000 after buying an additional 234,148 shares in the last quarter. 69.58% of the stock is owned by institutional investors.
About HealthStream
HealthStream, Inc provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company’s solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs.
See Also
- Five stocks we like better than HealthStream
- What Are Growth Stocks and Investing in Them
- AST SpaceMobile Stock Surges 17% After Analyst Upgrade
- What Are the U.K. Market Holidays? How to Invest and Trade
- 3 Stocks With Triple-Digit PEs That Are Still Worth a Look
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- SMCI Investors Use These ETFs For Heightened Exposure
Receive News & Ratings for HealthStream Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthStream and related companies with MarketBeat.com's FREE daily email newsletter.